Circulating immune and biochemical markers predict tumor response to immunotherapy in advanced melanoma and lung cancer.
- DOI
- 10.3389/fimmu.2026.1854351
- Published
- 2026
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2026.1854351,
title = {Circulating immune and biochemical markers predict tumor response to immunotherapy in advanced melanoma and lung cancer.},
author = {Sequero-Lopez S and Castillo-Barnes D and Gálvez-Carvajal L and Palazón-Carrión N and Martínez-Murcia FJ and de la Cruz-Merino L and Muñoz-Couselo E and Provencio M and Ortiz A and Górriz JM and Ramírez J and Rueda-Domínguez A and Blancas I},
year = {2026},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2026.1854351},
url = {https://doi.org/10.3389/fimmu.2026.1854351}
}RIS
TY - JOUR TI - Circulating immune and biochemical markers predict tumor response to immunotherapy in advanced melanoma and lung cancer. AU - Sequero-Lopez S AU - Castillo-Barnes D AU - Gálvez-Carvajal L AU - Palazón-Carrión N AU - Martínez-Murcia FJ AU - de la Cruz-Merino L AU - Muñoz-Couselo E AU - Provencio M AU - Ortiz A AU - Górriz JM AU - Ramírez J AU - Rueda-Domínguez A AU - Blancas I PY - 2026 JO - Frontiers in immunology DO - 10.3389/fimmu.2026.1854351 UR - https://doi.org/10.3389/fimmu.2026.1854351 ER -
APA
S, S., D, C., L, G., N, P., FJ, M., L, D. L. C., E, M., M, P., A, O., JM, G., J, R., A, R., & I, B. (2026). Circulating immune and biochemical markers predict tumor response to immunotherapy in advanced melanoma and lung cancer.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1854351
Source records
- pubmed · retrieved 2026-09-25T13:52:53.486Z